1-D-ribofuranosyl-5-bromouracil-nucleoside,
5-bromouridine,
bromouridine,
5-Bromouridine,
957-75-5,
Uridine, 5-bromo-,
1-beta-Ribofuranosyl-5-bromo-uracil,
bromouridine,
C9H11BrN2O6,
CHEBI:20553,
5-BROMO-URIDINE,
KEY8PG1BRC,
UNII-KEY8PG1BRC,
EINECS 213-486-6,
MFCD00006528,
NSC 38296,
5-Bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione,
BRN 0033664,
5-Bromouracil ribonucleoside,
5-bromo-1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione,
BRU,
1-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-bromo-1,3-dihyd ropyrimidine-2,4-dione,
5-bromo-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione,
5- Br-yuridine,
AK-87180,
5-Bromouridine, 98%,
Epitope ID:138106,
AC1L3M6S,
TimTec1_003895,
5-Bromo-uridine (5-BrU),
SCHEMBL41201,
5-24-06-00337 (Beilstein Handbook Reference),
CHEMBL2206658,
CTK8B2764,
AGFIRQJZCNVMCW-UAKXSSHOSA-N,
HMS1545B01,
ZINC1081233,
ANW-40745,
HG1067,
SBB005965,
5-Bromouracil-1-|A-D-ribofuranoside,
AKOS015834419,
AKOS015907263,
AM83946,
MCULE-2972277708,
NCGC00142488-01,
AJ-24920,
AN-48159,
DS-18294,
K730,
ST057083,
1-D-ribofuranosyl-5-bromouracil-nucleoside,
AB0014355,
AX8006761,
DB-057605,
LS-160803,
B0666,
FT-0620180,
A-8049,
16508-EP2281563A1,
16508-EP2316459A1,
957B755,
J-700087,
5-Bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione,
5-bromo-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione,
C9-H11-Br-N2-O6,
5-Bromouridine, 98% - 1G 1g,
CID91494,
cyclohexen-1-yl-(4-phenylphenyl)methanone,